Rite Aid (RAD) Misses Q4 EPS by 46c

Rite Aid (NYSE: RAD) reported Q4 EPS of ($1.24), $0.46 worse than the analyst estimate of ($0.78). Revenue for the quarter came in at $6.1 billion versus the consensus estimate of $5.65 billion.

For earnings history and earnings-related data on Rite Aid (RAD) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c